|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
|
|---|---|---|---|---|---|---|---|---|---|
| Current Assets | |||||||||
| Cash | |||||||||
| Prepaid expenses | |||||||||
| Total current assets | |||||||||
| Long-term prepaid insurance | |||||||||
| Marketable securities held in Trust Account | |||||||||
| TOTAL ASSETS | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued expenses | |||||||||
| Advances from related parties | |||||||||
| Related Party | |||||||||
| Total advances from related parties | |||||||||
| Due to Sponsor | |||||||||
| Total current liabilities | |||||||||
| Deferred underwriting fee payable | |||||||||
| Deferred underwriting fee payable | |||||||||
| TOTAL LIABILITIES | |||||||||
| Class A Ordinary Shares subject to possible redemption, 4,947,157 and 28,750,000 shares at redemption value of $10.91 and $10.72 per share as of June 30, 2026 and December 31, 2025, respectively | |||||||||
| Class A Ordinary Shares | |||||||||
| Total class A Ordinary Shares subject to possible redemption, 4,947,157 and 28,750,000 shares at redemption value of $10.91 and $10.72 per share as of June 30, 2026 and December 31, 2025, respectively | |||||||||
| Shareholders’ Deficit | |||||||||
| Ordinary shares, value | |||||||||
| Accumulated deficit | |||||||||
| Total Shareholders’ Deficit | |||||||||
| Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit |
Loading...
